Security key
83422E204
Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB)
CUSIP: 83422E204
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Total 13F shares
- 36,331,707
- Total 13F value
- $145,326,212
- Share change
- +420,811
- Put/Call ratio
- 4.8%
- SEC-reported price per share
- $4.00
- Number of holders
- 86
- Value change
- -$2,638,776
- Number of buys
- 46
- Number of sells
- 39
- Shares outstanding
- 92,783,558
Holder snapshot
7 signals
Show 1 more signal
Security identity
1 source field
Report period
Q4 2024
Institutions
86
Top holders
10
SLDB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
Solid Biosciences Inc. SEC filings
Solid Biosciences Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 83422E204
Recent filing periods:
Ownership snapshot
Top reported holders of SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
PERCEPTIVE ADVISORS LLC
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
Lead comparable stake: 7.4%
Showing 1-6 of 15 holder rows.
Quick read
PERCEPTIVE ADVISORS LLC leads the comparable SEC ownership view at 7.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
PERCEPTIVE ADVISORS LLC
7.4%
RA CAPITAL MANAGEMENT, L.P.
4.7%
Bain Capital Life Sciences Invest...
4.3%
Vestal Point Capital, LP
3%
Siren, L.L.C.
3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
7.4%
|
$48,139,322
6,906,646 shares
|
— | 30 Sep 2024 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
4.7%
|
$30,183,209
4,330,446 shares
|
— | 30 Sep 2024 |
| Bain Capital Life Sciences Investors, LLC |
13F
Company
|
4.3%
|
$28,121,037
4,034,582 shares
|
— | 30 Sep 2024 |
| Vestal Point Capital, LP |
13F
Company
|
3%
|
$19,516,000
2,800,000 shares
|
— | 30 Sep 2024 |
| Siren, L.L.C. |
13F
Individual
|
3%
|
$19,160,816
2,749,041 shares
|
— | 30 Sep 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
1.9%
|
$12,226,488
1,754,159 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
86
Shares
36,331,707
Rows available
86
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
90
Q4 2024 holders
86
Holder diff
-4
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend